NTSR2
Neurotensin receptor type 2
Also known as: NTR2, NTR2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O95665
- Gene
- NTSR2
- Ensembl
- ENSG00000169006
- Chromosome
- 2
- Canonical length
- 410 aa
- Protein class
- FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters
OverviewNCBI Gene
The protein encoded by this gene belongs to the G protein-coupled receptor family that activate a phosphatidylinositol-calcium second messenger system. Binding and pharmacological studies demonstrate that this receptor binds neurotensin as well as several other ligands already described for neurotensin NT1 receptor. However, unlike NT1 receptor, this gene recognizes, with high affinity, levocabastine, a histamine H1 receptor antagonist previously shown to compete with neurotensin for low-affinity binding sites in brain. These activities suggest that this receptor may be of physiological importance and that a natural agonist for the receptor may exist. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
410 residues, UniProt reviewed canonical sequence.
>O95665|NTSR2
1 METSSPRPPR PSSNPGLSLD ARLGVDTRLW AKVLFTALYA LIWALGAAGN ALSAHVVLKA
61 RAGRAGRLRH HVLSLALAGL LLLLVGVPVE LYSFVWFHYP WVFGDLGCRG YYFVHELCAY
121 ATVLSVAGLS AERCLAVCQP LRARSLLTPR RTRWLVALSW AASLGLALPM AVIMGQKHEL
181 ETADGEPEPA SRVCTVLVSR TALQVFIQVN VLVSFVLPLA LTAFLNGVTV SHLLALCSQV
241 PSTSTPGSST PSRLELLSEE GLLSFIVWKK TFIQGGQVSL VRHKDVRRIR SLQRSVQVLR
301 AIVVMYVICW LPYHARRLMY CYVPDDAWTD PLYNFYHYFY MVTNTLFYVS SAVTPLLYNA
361 VSSSFRKLFL EAVSSLCGEH HPMKRLPPKP QSPTLMDTAS GFGDPPETRTLocalizationUniProt · AlphaFold · HPA
Whether an antibody against NTSR2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.34
- Highest tissue expression
- 108 nTPM
Expression across tissuesHPA
Tissue
- basal ganglia: 108 nTPM
- midbrain: 92 nTPM
- amygdala: 75 nTPM
- cerebral cortex: 59 nTPM
- hypothalamus: 50 nTPM
- hippocampal formation: 38 nTPM
Single-cell type
- astrocytes: 55 nCPM
- ovarian stromal cells: 13 nCPM
- breast hormone-responsive cells: 5.1 nCPM
- granulosa cells: 4.9 nCPM
- undifferentiated spermatogonia: 2.7 nCPM
- endometrial stromal cells: 2.5 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- midbrain: 93 nTPM
- basal ganglia: 87 nTPM
- thalamus: 87 nTPM
- hypothalamus: 70 nTPM
- amygdala: 69 nTPM
- pons: 57 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.09
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.63
- DepMap mean gene effect
- 0.06
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell surface receptor signaling pathway
- neuropeptide signaling pathway
- phospholipase C-activating G protein-coupled receptor signaling pathway
- regulation of membrane potential
- sensory perception
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NTSR2 as an antibody target. Whether an autoantibody or antibody against NTSR2 could matter depends on whether native NTSR2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NTSR2 is annotated at the cell surface, where native NTSR2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label NTSR2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...